These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35807549)

  • 1. Pharmacological Properties of 4', 5, 7-Trihydroxyflavone (Apigenin) and Its Impact on Cell Signaling Pathways.
    Abid R; Ghazanfar S; Farid A; Sulaman SM; Idrees M; Amen RA; Muzammal M; Shahzad MK; Mohamed MO; Khaled AA; Safir W; Ghori I; Elasbali AM; Alharbi B
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
    Yang J; Pi C; Wang G
    Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention.
    Bridgeman BB; Wang P; Ye B; Pelling JC; Volpert OV; Tong X
    Cell Signal; 2016 May; 28(5):460-468. PubMed ID: 26876613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.
    Tong X; Pelling JC
    Anticancer Agents Med Chem; 2013 Sep; 13(7):971-8. PubMed ID: 23272913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apigetrin induces extrinsic apoptosis, autophagy and G2/M phase cell cycle arrest through PI3K/AKT/mTOR pathway in AGS human gastric cancer cell.
    Kim SM; Vetrivel P; Ha SE; Kim HH; Kim JA; Kim GS
    J Nutr Biochem; 2020 Sep; 83():108427. PubMed ID: 32559585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cucurbitacin E shows synergistic effect with sorafenib by inducing apoptosis in hepatocellular carcinoma cells and regulates Jak/Stat3, ERK/MAPK, PI3K/Akt/mTOR signaling pathways.
    Üremiş MM; Üremiş N; Türköz Y
    Steroids; 2023 Oct; 198():109261. PubMed ID: 37355001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-κB signaling.
    Erdogan S; Doganlar O; Doganlar ZB; Serttas R; Turkekul K; Dibirdik I; Bilir A
    Life Sci; 2016 Oct; 162():77-86. PubMed ID: 27569589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells.
    Li C; Gao H; Feng X; Bi C; Zhang J; Yin J
    J Biochem Mol Toxicol; 2020 Dec; 34(12):e22597. PubMed ID: 32762018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apigenin Reduces Survival of Choriocarcinoma Cells by Inducing Apoptosis via the PI3K/AKT and ERK1/2 MAPK Pathways.
    Lim W; Park S; Bazer FW; Song G
    J Cell Physiol; 2016 Dec; 231(12):2690-9. PubMed ID: 26970256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells.
    Zhao G; Han X; Cheng W; Ni J; Zhang Y; Lin J; Song Z
    Oncol Rep; 2017 Apr; 37(4):2277-2285. PubMed ID: 28260058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK/STAT3, MAPK/ERK, and AKT/mTOR signaling pathways in HepG2 cell line.
    Üremiş N; Üremiş MM; Çiğremiş Y; Tosun E; Baysar A; Türköz Y
    J Food Biochem; 2022 Oct; 46(10):e14333. PubMed ID: 35866877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationalizing the therapeutic potential of apigenin against cancer.
    Ahmed SA; Parama D; Daimari E; Girisa S; Banik K; Harsha C; Dutta U; Kunnumakkara AB
    Life Sci; 2021 Feb; 267():118814. PubMed ID: 33333052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers.
    Reddy D; Kumavath R; Tan TZ; Ampasala DR; Kumar AP
    Life Sci; 2020 Jan; 241():117147. PubMed ID: 31830480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways.
    Mehdi Üremiş M; Üremiş N; Tosun E; Durhan M; Çiğremiş Y; Baysar A; Türköz Y
    Curr Cancer Drug Targets; 2022; 22(11):931-944. PubMed ID: 35786188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovatodiolide and antrocin synergistically inhibit the stemness and metastatic potential of hepatocellular carcinoma via impairing ribosome biogenesis and modulating ERK/Akt-mTOR signaling axis.
    Chen MY; Hsu CH; Setiawan SA; Tzeng DTW; Ma HP; Ong JR; Chu YC; Hsieh MS; Wu ATH; Tzeng YM; Yeh CT
    Phytomedicine; 2023 Jan; 108():154478. PubMed ID: 36265255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways.
    El-Hanboshy SM; Helmy MW; Abd-Alhaseeb MM
    Mol Biol Rep; 2021 Nov; 48(11):7233-7242. PubMed ID: 34596810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
    Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
    Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells.
    Jiang S; Wang Q; Feng M; Li J; Guan Z; An D; Dong M; Peng Y; Kuerban K; Ye L
    Appl Microbiol Biotechnol; 2017 Feb; 101(4):1535-1546. PubMed ID: 27807662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma.
    Ha SE; Kim SM; Vetrivel P; Kim HH; Bhosale PB; Heo JD; Lee HJ; Kim GS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apigenin reduces the Toll-like receptor-4-dependent activation of NF-κB by suppressing the Akt, mTOR, JNK, and p38-MAPK.
    Kim A; Lee CS
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):271-283. PubMed ID: 29264665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.